Thomas Woiwode - 29 Apr 2022 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: TPST
Reported as of: 29 Apr 2022
Net transaction value: +$5,000,000
SEC form: 4
Accepted by SEC: 03 May 2022, 17:49:06 UTC
Prior SEC filing: 27 Aug 2021
Next SEC filing: 31 May 2022
Source filing: View source filing
Reporting owner signature: /s/ Robin Praeger, attorney-in-fact for Thomas Woiwode

Key filing fact

Thomas Woiwode filed Form 4 for Tempest Therapeutics, Inc. (TPST) on 03 May 2022.

Key facts

This page summarizes Thomas Woiwode's Form 4 filing for Tempest Therapeutics, Inc. (TPST).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 May 2022, 17:49.

Change

Previous filing in this sequence was filed on 27 Aug 2021.
Current net transaction value: +$5,000,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TPST transaction

Common Stock

Purchase

Transaction value: $5,000,000
Shares: +2,118,644
Change %
Price: $2.36
Shares after: 2,118,644
Date: 29 Apr 2022
Ownership: See Footnote
Footnotes: F1, F2

TPST holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 997,940
Date: 29 Apr 2022
Ownership: See Footnote
Footnotes: F3

TPST holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,171,094
Date: 29 Apr 2022
Ownership: See Footnote
Footnotes: F4

TPST holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,377
Date: 29 Apr 2022
Ownership: See Footnote
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents shares acquired pursuant to a Securities Purchase Agreement dated April 26, 2022 between the Issuer, Versant Vantage II, L.P. ("Vantage II") and certain other investors.

Footnote F2

These shares are held of record by Vantage II. Versant Vantage II GP, L.P. ("Vantage II GP") is the general partner of Vantage II, and Versant Vantage II GP-GP, LLC ("Vantage II GP-GP") is the general partner of Vantage II GP. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Vantage II GP-GP and may be deemed to share voting and dispositive power over the shares held by Vantage II. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein.

Footnote F3

These shares are held of record by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP, L.P. ("VV VI GP") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC ("VV VI GP-GP") is the general partner of VV VI GP. The Reporting Person, a member of the Issuer's board of directors, is a managing director of VV VI GP-GP and may be deemed to share voting and dispositive power over the shares held by VVC VI. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein.

Footnote F4

These shares are held of record by Versant Venture Capital IV, L.P. ("VVC IV"). Versant Ventures IV, LLC ("VV IV") is the general partner of VVC IV. The Reporting Person, a member of the Issuer's board of directors, is a managing director of VV IV and may be deemed to share voting and dispositive power over the shares held by VVC IV. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein.

Footnote F5

These shares are held of record by Versant Side Fund IV, L.P. ("VSF IV"). VV IV is the general partner of VSF IV. The Reporting Person, a member of the Issuer's board of directors, is a managing director of VV IV and may be deemed to share voting and dispositive power over the shares held by VSF IV. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein.